Oncosil Medical Ltd has released a press release.
Preliminary Final Report - Appendix 4E Announcement
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from OncoSil Medical
- HDE filing submitted in US for Bile Duct Cancer treatment
- OncoSil presents clinical data at ESMO World Congress
- OncoSil files for TGA registration
- OncoSil receives Singapore regulatory approval
- Allotment of Securities under Institutional Placement
Later from OncoSil Medical
- OncoSil receives Malaysian regulatory approval
- Investor Update
- Receipt of $2.8m R&D Tax Incentive Refund
- Positive PanCO trial update on resected cohort
- OncoSil achieves first commercial sale
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical